KinBio

Pharmaceuticals

Health Tech & Life Sciences
Non Active, Jan 2025 ceased to operate
Pre-Funding Hong Kong Founded 2018
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
18
HQ
Hong Kong
Sector
Health Tech & Life Sciences

About

KinBio is wholly-owned local subsidiary of Hong Kong-based pharmaceutical and food retailer Gencor Pacific which had acquired the assets of Israel-based pharmaceutical company InSight. KinBio is developing a large portfolio of technologies for manufacturing generic versions of complex drugs, high-quality biosimilars and biologics. The company is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoporosis. .

Q&A

What is the current status of KinBio?
KinBio is currently inactive, having ceased operations in January 2025.
When was KinBio founded?
KinBio was founded in November 2018.
What is KinBio's primary business focus?
KinBio specializes in the research, development, manufacturing, and global commercialization of biosimilars for various therapeutic areas, including CNS, inflammation, oncology, and osteoporosis.
What is KinBio's relationship with Gencor Pacific?
KinBio is a wholly-owned local subsidiary of Hong Kong-based pharmaceutical and food retailer Gencor Pacific, which acquired the assets of Israel-based pharmaceutical company InSight.
What is the product stage of KinBio's offerings?
KinBio's products are in the clinical trial stage.
Who are the key executives at KinBio?
Key executives at KinBio include Dror Melamed as CTO and Nitzan Levy as General Manager.
What is KinBio's primary sector classification?
KinBio's primary sector is Health Tech & Life Sciences.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Business model
B2B

Tags

pharmaceuticalsoncology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/18997598

Identifiers & details

Founded2018-11
Employees (exact)18
Status reasonNon Active, Jan 2025 ceased to operate